Table 5. SMA-MAP analytes and their correlated outcomes.
Analyte | Correlated Outcome Measures |
APOB | CMAP, Strength |
APCS | Motor |
ASHG | Motor, PD, CMAP, Strength |
AXL | FVC, Motor, PD?, PQP |
CCL2 | PD? |
CD93 | Motor, MUNE, PQC, Strength |
CFH | Motor |
CDH13 | Motor |
CHI3L1 | Motor |
CLEC3B | Motor, PQC |
COMP | Motor, MUNE, Strength |
CRP | Motor, PD? |
CTSD | Motor |
DPP4 | Motor, MUNE, PQP, Strength |
ENG | Motor, PD? |
ERBB2 | CHOP-TOSS, Motor, PD? |
FBLN1 | FVC, Motor, PD?, Strength |
IGF1 | PD? |
IGFBP6 | Motor, PD? |
LEP | Motor |
LUM | CMAP, Motor, MUNE, PD? Strength |
MB | FVC, Motor, Strength |
PEPD | CMAP, Motor, MUNE, Strength |
PGF | Motor, MUNE, PD? |
SPP1 | Motor |
THBS4 | Motor, MUNE, PD? |
TNXB | Motor |
CHOP-TOSS = Children’s Hospital of Philadelphia Test of Strength, FVC = forced vital capacity, Motor = motor function scale (e.g. MHFMS, HFMS, HFMSE, GMFM), PD = SMN pharmacodynamic measure, CMAP = compound motor action potential, MUNE = motor unit number estimation, PQP = PedQL quality of life, parent score, PQC = PedQL quality of life, child score, CHOP-TOSS = Children’s Hospital of Philadelphia Test of Strength.